Nutrien Q2 Adj EPS $2.53 Misses $2.81 Estimate, Sales $11.65B Beat $11.16B Estimate
Portfolio Pulse from Benzinga Newsdesk
Nutrien (NYSE:NTR) reported Q2 adjusted earnings of $2.53 per share, missing the analyst consensus estimate of $2.81 by 9.96%. This is a 56.75% decrease from the same period last year. However, the company's quarterly sales of $11.65 billion beat the analyst consensus estimate of $11.16 billion by 4.43%, despite being a 19.66% decrease from the same period last year.
August 04, 2023 | 12:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Nutrien's Q2 earnings missed estimates and decreased significantly from last year, which could negatively impact the stock. However, the sales beat estimates, which could offset some of the negative impact.
Earnings reports are a major factor in a company's stock price. Nutrien's significant earnings miss and decrease from last year could negatively impact the stock. However, the fact that sales beat estimates could provide some positive sentiment among investors, potentially offsetting some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100